FDA Inspection 1300286 — GTX Technologies
The FDA completed an inspection of GTX Technologies on January 29, 2026 in Amarillo, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 8 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 29, 2026
- Fiscal Year
- 2026
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Amarillo, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 15939 | 21 CFR 111.105(g) | Quality control - reserve samples |
| 15952 | 21 CFR 111.113 | Quality control operations - material review, disposition |
| 18154 | 21 CFR 117.80(a)(2) | Appropriate quality control operations |
| 22699 | 21 CFR 117.80(b)(1) | Raw material control - Inspection |
| 22813 | 21 CFR 111.553 | Written procedures - establish; product complaint |
| 22843 | 21 CFR 111.70(b) | Specifications - components |
| 22847 | 21 CFR 111.70(e) | Specifications - finished dietary supplement |
| 22908 | 21 CFR 111.503 | Written procedures - establish; returned dietary supplements |